Cargando…

Teicoplanin Dosing Strategy for Treatment of Staphylococcus aureus in Korean Patients with Neutropenic Fever

PURPOSE: The present study was conducted to determine and compare the target attainment rate (TAR) between microorganism-nonspecific (C(trough)) and microorganism-specific (AUC(24)/MIC) targets over two weeks of teicoplanin administration according to several dose regimens for the treatment of Staph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Byung-Jin, Yim, Dong-Seok, Lee, Dong-Gun, Kwon, Jae-Cheol, Kim, Si-Hyun, Choi, Su-Mi
Formato:	Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104459/ https://www.ncbi.nlm.nih.gov/pubmed/21623604 http://dx.doi.org/10.3349/ymj.2011.52.4.616

Ejemplares similares

Immobilised teicoplanin does not demonstrate antimicrobial activity against Staphylococcus aureus
por: Britton, S., et al.
Publicado: (2022)

Increased incidence of teicoplanin-non-susceptible Staphylococcus epidermidis strains: a 6-year retrospective study
por: Kim, Subin, et al.
Publicado: (2023)

Phenotypic Modifications in Staphylococcus aureus Cells Exposed to High Concentrations of Vancomycin and Teicoplanin
por: Gonçalves, Fábio D. A., et al.
Publicado: (2016)

Impact of teicoplanin maintenance dose and MIC values on the clinical outcomes of patients treated for methicillin-resistant Staphylococcus aureus bacteremia
por: Tsai, Ching-Yen, et al.
Publicado: (2018)

Comparison of mortality and clinical failure rates between vancomycin and teicoplanin in patients with methicillin-resistant Staphylococcus aureus pneumonia
por: Lee, Jang Ho, et al.
Publicado: (2022)

Neutropenic Fever
por: Baluch, Aliyah, et al.
Publicado: (2019)

Teicoplanin combined with conventional vancomycin therapy for the treatment of pulmonary methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis infections
por: Wu, Wei, et al.
Publicado: (2021)

Staphylococcus lugdunensis Urinary Tract Infection With Associated Neutropenic Fever
por: Bobde, Rajanish, et al.
Publicado: (2022)

Vancomycin, teicoplanin, daptomycin, and linezolid MIC creep in methicillin-resistant Staphylococcus aureus is associated with clonality
por: Hsieh, Yu-Chia, et al.
Publicado: (2016)

Teicoplanin associated gene tcaA inactivation increases persister cell formation in Staphylococcus aureus
por: Habib, Gul, et al.
Publicado: (2023)

Current Antimicrobial Usage for the Management of Neutropenic Fever in Korea: A Nationwide Survey
por: Choi, Su-Mi, et al.
Publicado: (2008)

Prognosis of patients with methicillin-resistant Staphylococcus aureus bloodstream infection treated with teicoplanin: a retrospective cohort study investigating effect of teicoplanin minimum inhibitory concentrations
por: Wang, Jann-Tay, et al.
Publicado: (2013)

Teicoplanin versus β-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia
por: Tsai, Ching-Yen, et al.
Publicado: (2021)

Evidence-Based Guidelines for Empirical Therapy of Neutropenic Fever in Korea
por: Lee, Dong-Gun, et al.
Publicado: (2011)

Comparison of teicoplanin disk diffusion and broth microdilution methods against clinical isolates of Staphylococcus aureus and S. epidermidis
por: Camargo, Carlos Henrique, et al.
Publicado: (2011)

Detection and Control of Biofilm Formation by Staphylococcus aureus from Febrile Neutropenic Patient
por: El-Nagdy, Ahmed Hazem, et al.
Publicado: (2020)

Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study
por: Cho, Sung-Yeon, et al.
Publicado: (2013)

Activities of vancomycin, teicoplanin and linezolid against bacteraemic methicillin-resistant Staphylococcus aureus strains in Gauteng, South Africa
por: Botha, ME, et al.
Publicado: (2009)

Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration
por: Peeters, Olivier, et al.
Publicado: (2016)

Therapeutic Drug Concentrations of Teicoplanin in Clinical Settings
por: Nah, So-Yun, et al.
Publicado: (2014)

Population Pharmacokinetics and Model-Based Dosing Optimization of Teicoplanin in Pediatric Patients
por: Zhang, Tao, et al.
Publicado: (2020)

Association between daptomycin susceptibility and teicoplanin resistance in Staphylococcus epidermidis
por: Watanabe, Shinichi, et al.
Publicado: (2019)

Intravenous Itraconazole vs. Amphotericin B Deoxycholate for Empirical Antifungal Therapy in Patients with Persistent Neutropenic Fever
por: Park, Sun Hee, et al.
Publicado: (2006)

Therapeutic Drug Level Monitoring of Teicoplanin in Korean Pediatric Patients with Normal versus Impaired Renal Function
por: Choi, Joon-sik, et al.
Publicado: (2020)

Vascular graft infection by Staphylococcus aureus: efficacy of linezolid, teicoplanin and vancomycin systemic prophylaxis protocols in a rat model
por: Atahan, Erhan, et al.
Publicado: (2009)

Efficacy of Linezolid, Teicoplanin, and Vancomycin in Prevention of an Experimental Polytetrafluoroethylene Graft Infection Model caused by Methicillin-Resistant Staphylococcus aureus
por: Mese, Bulent, et al.
Publicado: (2015)

Daptomycin versus teicoplanin for bloodstream infection due to methicillin-resistant Staphylococcus aureus with a high teicoplanin minimal inhibitory concentration ≥1.5 mg/L: a propensity score-based analysis
por: Tsai, Ching-Yen, et al.
Publicado: (2018)

Efficacy of Lefamulin Against Staphylococcus aureus-Induced Bacteremia in a Neutropenic and Immunocompetent Murine Model
por: Fischer, Evelin, et al.
Publicado: (2017)

Pharmacokinetics/pharmacodynamics of lefamulin in a neutropenic murine pneumonia model with Staphylococcus aureus and Streptococcus pneumoniae
por: Wicha, Wolfgang W, et al.
Publicado: (2019)

Blood Culture in Neutropenic Patients with Fever
por: Meidani, Mohsen, et al.
Publicado: (2012)

COVID-19 presenting as neutropenic fever
por: Spencer, Hunter C., et al.
Publicado: (2020)

Neutropenic Fever in the Intensive Care Unit
por: Stephens, R. Scott
Publicado: (2019)

Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India
por: Bakthavatchalam, Yamuna Devi, et al.
Publicado: (2019)

Dynamic Changes of Staphylococcus aureus Susceptibility to Vancomycin, Teicoplanin, and Linezolid in a Central Teaching Hospital in Shanghai, China, 2008–2018
por: Jian, Ying, et al.
Publicado: (2020)

Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
por: Chen, Chao‐Yang, et al.
Publicado: (2023)

Vancomycin Dosing in Neutropenic Patients
por: Haeseker, Michiel B., et al.
Publicado: (2014)

Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA
por: Lai, Chih-Cheng, et al.
Publicado: (2017)

408 The Comparison of in-vitro Activity of Daptomycin with Vancomycin and Teicoplanin against Methicillin-Resistant Staphylococcus aureus Strains Isolated from Bloodstream Infections
por: Demirdal, Tuna, et al.
Publicado: (2014)

Predicting the complicated neutropenic fever in the emergency department
por: Moon, J M, et al.
Publicado: (2009)

Ceftazidime for Neutropenic Fevers: Is It Still an Appropriate Choice?
por: Napier, Ellen Bethany
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a55rri1ghtabqu3h6klgtij1gg